US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2025-2033

US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A723

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
    2.6    Study Assumptions
3   Executive Summary
4   An Overview of Healthcare Advertising in the United States
5   What Drives the Healthcare Advertising Market in the US?

    5.1    Digitalization and other Technological Advancements
    5.2    Increasing Presence of Generic and Me-too Drugs
    5.3    Government Regulations Supporting DTC Advertising
    5.4    Launch of New Drugs
    5.5    Increased Consumer Reach through Mobile Advertising
    5.6    Other Key Drivers
6   Healthcare Advertising Market: Value Chain
    6.1    DTC Advertising
    6.2    Detailing
7   Current Trends in Healthcare Advertising
    7.1    Focus on Content
    7.2    Rise of Multichannel Marketing
    7.3    Targeting Consumers with Local Advertising
    7.4    Reliance on Social Media
    7.5    Surging Mobile Marketing
    7.6    Consumers Becoming Researchers
    7.7    Information Dispensed through Videos
    7.8    Increasing Importance of Online Reviews
8   US Healthcare Advertising Market: SWOT Analysis
    8.1    Overview
    8.2    Strengths
    8.3    Weaknesses
    8.4    Opportunities
    8.5    Threats
9   US Healthcare Advertising Market: Porter’s Five Forces Analysis
    9.1    Overview
    9.2    Bargaining Power of Buyers
    9.3    Bargaining Power of Suppliers
    9.4    Degree of Rivalry
    9.5    Threat of New Entrants
    9.6    Threat of Substitutes
10  US Healthcare Advertising Market
    10.1    Historical and Current Market Trends
    10.2    Impact of COVID-19
    10.3    Market Breakup by Product Type
        10.3.1    Pharmaceuticals (Small Molecule Drugs) Advertising Market
            10.3.1.1    Historical, Current and Future Trends 
            10.3.1.2    Market Breakup by Advertising Channel
            10.3.1.3    Advertising Spend by Key Players
        10.3.2    Biopharmaceuticals Market
            10.3.2.1    Historical, Current and Future Market Trends 
            10.3.2.2    Market Breakup by Advertising Channel
            10.3.2.3    Advertising Spend by Key Players
        10.3.3    Vaccines Market
            10.3.3.1    Historical, Current and Future Market Trends 
            10.3.3.2    Market Breakup by Advertising Channel
            10.3.3.3    Advertising Spend by Key Players
        10.3.4    Over-the-Counter Drugs Market
            10.3.4.1    Historical, Current and Future Market Trends 
            10.3.4.2    Market Breakup by Channel
            10.3.4.3    Advertising Spend by Key Players
11  Major Players: Sales and Advertising Spend
    11.1    Advertising Spend by Major Pharma Companies
        11.1.1    Johnson & Johnson
            11.1.1.1    US Sales
            11.1.1.2    Advertising Spend by Channel
            11.1.1.3    Global Sales and Advertising Spend
        11.1.2    Pfizer
            11.1.2.1    US Sales
            11.1.2.2    Advertising Spend by Channel
            11.1.2.3    Global Sales and Advertising Spend
        11.1.3    Merck & Co.
            11.1.3.1    US Sales
            11.1.3.2    Advertising Spend on Different Segments
            11.1.3.3    Global Sales and Advertising Spend
        11.1.4    Glaxosmith Kline
            11.1.4.1    US Sales
            11.1.4.2    Advertising Spend on Different Segments
            11.1.4.3    Global Sales and Advertising Spend
        11.1.5    Eli Lilly
            11.1.5.1    US Sales
            11.1.5.2    Advertising Spend on Different Segments
            11.1.5.3    Global Sales and Advertising Spend
        11.1.6    Novartis
            11.1.6.1    US Sales
            11.1.6.2    Total Sales of Different Segments
            11.1.6.3    Global Sales and Advertising Spend
            11.1.6.4    Global Sales and Advertising Spend
        11.1.7    Sanofi
            11.1.7.1    US Sales
            11.1.7.2    Advertising Spend on Different Segments
            11.1.7.3    Global Sales and Advertising Spend
        11.1.8    AstraZeneca
            11.1.8.1    US Sales
            11.1.8.2    Advertising Spend on Channel
            11.1.8.3    Global Sales and Advertising Spend
        11.1.9    Roche
            11.1.9.1    US Sales
            11.1.9.2    Advertising Spend on Different Segments
            11.1.9.3    Global Sales and Advertising Spend
        11.1.10    Bayer Healthcare
            11.1.10.1    US Sales
            11.1.10.2    Advertising Spend on Different Channel
            11.1.10.3    Global Sales and Advertising Spend
        11.1.11    Bristol- Myers Squibb
            11.1.11.1    US Sales
            11.1.11.2    Advertising Spend by Channels
            11.1.11.3    Global Sales and Advertising Spend
12  Market Challenges
    12.1    Trust Gap between Consumers and Advertisers
    12.2    Strict Rules and Regulations by FDA
    12.3    Unethical Practices
    12.4    Macroeconomic Scenario
    12.5    Other Challenges

List of Figures

Figure 1: US: Breakup of Healthcare Market
Figure 2: US: Healthcare Industry Digital Ad Spending (in Billion USD), 2019-2024
Figure 3: United States: Healthcare Advertising Industry: Value Chain Analysis of DTC Advertising
Figure 4: US: Healthcare Advertising Industry: SWOT Analysis
Figure 5: US: Healthcare Advertising Industry: Porter’s Five Forces Analysis
Figure 6: US: Healthcare Advertising Market: Sales Value (in Billion USD), 2019-2024
Figure 7: US: Healthcare Advertising Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: US: Healthcare Advertising Market: Breakup by Product Type (in %), 2024
Figure 9: US: Pharmaceutical (Small Molecule Drugs) Market: Sales Value (in Billion USD), 2019-2024
Figure 10: US: Pharmaceutical (Small Molecule Drugs) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 11: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend (in Billion USD), 2019-2024
Figure 12: US: Pharmaceutical (Small Molecule Drugs) Market Forecast: Advertising Spend (in Billion USD), 2025-2033
Figure 13: US: Pharmaceutical (Small Molecule Drugs) Market Advertising Spend Breakup by Channels (in Billion USD), 2019-2024
Figure 14: US: Biopharmaceutical Market: Sales Value (in Billion USD), 2019-2024
Figure 15: US: Biopharmaceutical Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 16: US: Biopharmaceutical Market: Advertising Spend (in Billion USD), 2019-2024
Figure 17: US: Biopharmaceutical Market Forecast: Advertising Spending (in Billion USD), 2025-2033
Figure 18: US: Biopharmaceutical Market: Advertising Spend: Breakup by Channels (in %), 2024
Figure 19: US: Biopharmaceutical Market: Advertising Spend: Breakup by Different Providers (in %), 2024
Figure 20: US: Vaccines Market: Sales Value (in Billion USD), 2019-2024
Figure 21: US: Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 22: US: Vaccines Market: Advertising Spend (in Billion USD), 2019-2024
Figure 23: US: Vaccines Market Forecast: Advertising Spend (in Billion USD), 2025-2033
Figure 24: US: OTC Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 25: US: OTC Drugs Market: Sales Forecast (in Billion USD), 2025-2033
Figure 26: US: OTC Drugs Market: Advertising Spend (in Billion USD), 2019-2024
Figure 27: US: OTC Drugs Market Forecast: Advertising Spend (in Billion USD), 2025-2033
Figure 28: US: OTC Drugs Market: Advertising Spend: Breakup by Channels (in %)
Figure 29: US: Advertising Spend by Top Companies Breakup (in %),
Figure 30: US: Pharmaceutical Marketing: Expenditure Breakup by Type (in %), 
Figure 31: Johnson & Johnson: The US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 32: Johnson & Johnson: Advertising Spend: Breakup by Different Channels (in %), 2018
Figure 33: Johnson & Johnson: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 34: Pfizer: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 35: Pfizer: Advertising Spend: Breakup by Different Channels in the US (in %), 2018
Figure 36: Pfizer: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 37: Merck & Co.: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 38: Merck & Co.: Breakup of Spending on Different Divisions (in %), 2018
Figure 39: Merck & Co.: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 40: Glaxosmith Kline: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 41: GSK: Breakup of Spending on Different Channels (in %), 2018
Figure 42: GSK: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 43: Eli Lilly: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 44: Eli Lilly: Breakup of Spending on Different Channel (in %), 2018
Figure 45: Eli Lilly: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 46: Novartis: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 47: Novartis: Breakup of Spending on Different Channel (in %), 2018
Figure 48: Novartis: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 49: Sanofi: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 50: Sanofi: Breakup of Spending on Different Products (in %), 2016
Figure 51: Sanofi: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 52: AstraZeneca: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 53: AstraZeneca: Advertising Spend: Breakup by Different Channels in the US (in %), 2013
Figure 54: AstraZeneca: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 55: Roche: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 56: Roche: Breakup of Spending on Different Divisions (in %), 2016
Figure 57: Roche: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 58: Bayer Healthcare: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 59: Bayer Healthcare: Breakup of Spending on Different Channels (in %), 2016
Figure 60: Bayer Healthcare: Global Sales and Advertising Spend (in Billion USD), 2015-2018
Figure 61: Bristol-Myers Squibb: US and Rest of the World Sales (in Billion USD), 2015-2018
Figure 62: Bristol-Myers Squibb: Breakup of Spending on Different Channels (in %), 2015
Figure 63: Bristol-Myers Squibb: Global Sales and Advertising Spend (in Billion USD), 2015-2018

List of Tables

Table 1: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend by Key Players
Table 2: US: Biopharmaceutical Market: Advertising Spend by Key Players (in USD Million)
Table 3: US: Vaccines Market: Advertising Spend by Key Players
Table 4: US: OTC Drugs Market: Advertising Spend by Key Players
Table 5: US: Advertising Spend by Major Players, (in Million USD)
Table 6: Merck & Co.: Total Spending on Different Divisions (in Million USD), 2018
Table 7: GSK: Advertising Spend on Different Channels (in Million USD), 2018
Table 8: Eli Lilly: Advertising Spend on Different Channels (in Million USD), 2018
Table 9: Novartis: Total Sales of Different Segments (in Million USD), 2018
Table 10: Sanofi: Advertising Spend on Different Products (in Million USD), 2016
Table 11: AstraZeneca: Advertising Spend on Different Channels in the US (in USD Million), 2013
Table 12: Roche: Total Spending on Different Divisions (in Million USD), 2016

US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials